399 related articles for article (PubMed ID: 1689659)
1. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PMA-induced human T cell proliferation by bryostatin is associated with enhanced degradation of conventional protein kinase C (cPKC): Ca2+ signals restore mitogenic activity without abrogating enhanced cPKC degradation.
Galron D; Tamir A; Altman A; Isakov N
Cell Immunol; 1994 Oct; 158(1):195-207. PubMed ID: 8087865
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C.
Isakov N; Galron D; Mustelin T; Pettit GR; Altman A
J Immunol; 1993 Feb; 150(4):1195-204. PubMed ID: 8432975
[TBL] [Abstract][Full Text] [Related]
4. Activation of human T lymphocytes by bryostatin.
Hess AD; Silanskis MK; Esa AH; Pettit GR; May WS
J Immunol; 1988 Nov; 141(10):3263-9. PubMed ID: 3263418
[TBL] [Abstract][Full Text] [Related]
5. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
6. Tumor-promoting phorbol esters stimulate the proliferation of interleukin-3 dependent cells.
Hogans BB; Spivak JL
J Cell Physiol; 1988 Nov; 137(2):346-52. PubMed ID: 3142884
[TBL] [Abstract][Full Text] [Related]
7. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
Levine BL; May WS; Tyler PG; Hess AD
J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
[TBL] [Abstract][Full Text] [Related]
8. Posttranslational regulation of Lck and a p36-38 protein by activators of protein kinase C: differential effects of the tumor promoter, PMA, and the non-tumor-promoter, bryostatin.
Galron D; Ansotegui IJ; Isakov N
Cell Immunol; 1997 Jun; 178(2):141-51. PubMed ID: 9225005
[TBL] [Abstract][Full Text] [Related]
9. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
[TBL] [Abstract][Full Text] [Related]
10. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
11. Analysis of isolated and combined effects of calcium ionophore and phorbol ester on T lymphocyte activation.
Nóbrega AF; Maldonado MS; Dos Reis GA
Clin Exp Immunol; 1986 Sep; 65(3):559-69. PubMed ID: 3096619
[TBL] [Abstract][Full Text] [Related]
12. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
[TBL] [Abstract][Full Text] [Related]
13. Co-induction of lymphokine synthesis by the antineoplastic bryostatins.
Mohr H; Pettit GR; Plessing-Menze A
Immunobiology; 1987 Nov; 175(5):420-30. PubMed ID: 3123367
[TBL] [Abstract][Full Text] [Related]
14. Expression of proto-oncogene c-jun during differentiation of B-chronic lymphocytic leukemia.
Gignac SM; Buschie M; Pettit GR; Hoffbrand AV; Drexler HG
Leukemia; 1990 Jun; 4(6):441-4. PubMed ID: 2113601
[TBL] [Abstract][Full Text] [Related]
15. Synergistic action of A23187 and phorbol ester on human B cell activation.
Clevers HC; Versteegen JM; Logtenberg T; Gmelig-Meyling FH; Ballieux RE
J Immunol; 1985 Dec; 135(6):3827-30. PubMed ID: 3934268
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
[TBL] [Abstract][Full Text] [Related]
17. Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin-1 and phorbol ester activation pathways in the EL4-6.1 thymoma cell line.
Dornand J; Bouaboula M; d'Angeac AD; Favero J; Shire D; Casellas P
J Cell Physiol; 1992 Apr; 151(1):71-80. PubMed ID: 1560050
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
[TBL] [Abstract][Full Text] [Related]
19. Anti-Ig-mediated proliferation of human B cells in the absence of protein kinase C.
Francois DT; Katona IM; June CH; Wahl LM; Feuerstein N; Huang KP; Mond JJ
J Immunol; 1988 May; 140(10):3338-43. PubMed ID: 3129493
[TBL] [Abstract][Full Text] [Related]
20. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
Liles WC; Meier KE; Henderson WR
J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
